SEC Comment Letter 0000000000-24-003360 to AETHLON MEDICAL INC (AEMD)
AETHLON MEDICAL INC
Date: March 28, 2024 · CIK: 0000882291 · Accession: 0000000000-24-003360
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-278188
Letter
United States securities and exchange commission logo March 28, 2024 James Frakes Interim Chief Executive Officer Aethlon Medical, Inc. 11555 Sorrento Valley Road Suite 203 San Diego, CA 92121 Re:Aethlon Medical, Inc. Registration Statement on Form S-1 Filed March 22, 2024 File No. 333-278188 Dear James Frakes: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Robert Augustin at 202-551-8483 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Julie Robinson, Esq.
Show Raw Text
United States securities and exchange commission logo
March 28, 2024
James Frakes
Interim Chief Executive Officer
Aethlon Medical, Inc.
11555 Sorrento Valley Road
Suite 203
San Diego, CA 92121
Re:Aethlon Medical, Inc.
Registration Statement on Form S-1
Filed March 22, 2024
File No. 333-278188
Dear James Frakes:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Robert Augustin at 202-551-8483 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc: Julie Robinson, Esq.